Antidepressant treatment restores brain-derived neurotrophic factor serum levels and ameliorates motor function in Parkinson disease patients.
Valerio
V
Ricci
Massimiliano
M
Pomponi
Giovanni
G
Martinotti
Annarita
A
Bentivoglio
Giovanna
G
Loria
Sergio
S
Bernardini
Carlo
C
Caltagirone
Pietro
P
Bria
Francesco
F
Angelucci
D000928:Antidepressive Agents / Q000494:pharmacology* / Q000627:therapeutic use; D000978:Antiparkinson Agents / Q000627:therapeutic use; D019208:Brain-Derived Neurotrophic Factor / Q000097:blood / Q000187:drug effects*; D016022:Case-Control Studies; D003863:Depression / Q000150:complications / Q000188:drug therapy*; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D051100:Glial Cell Line-Derived Neurotrophic Factor / Q000097:blood; D006801:Humans; D008297:Male; D010300:Parkinson Disease / Q000150:complications / Q000188:drug therapy*; D017367:Selective Serotonin Reuptake Inhibitors / Q000494:pharmacology / Q000627:therapeutic use
D000928:Antidepressive Agents; D000978:Antiparkinson Agents; D019208:Brain-Derived Neurotrophic Factor; D051100:Glial Cell Line-Derived Neurotrophic Factor; D017367:Selective Serotonin Reuptake Inhibitors; C495039:GDNF protein, human